Li Q, Han X, Dong M, Bai L, Zhang W, Liu W
Inflammation. 2025; .
PMID: 40011292
DOI: 10.1007/s10753-025-02267-8.
Fu X, Shi X, Yin R, Xing C, Ma A
Sci Rep. 2025; 15(1):6517.
PMID: 39987236
PMC: 11846934.
DOI: 10.1038/s41598-025-91334-z.
Fan W, Zheng J, Jiang F
BMC Med Genomics. 2025; 18(1):31.
PMID: 39934808
PMC: 11817822.
DOI: 10.1186/s12920-025-02098-4.
Wu Z, Fan H, Qin L, Niu X, Chu B, Zhang K
J Mol Neurosci. 2025; 75(1):4.
PMID: 39743646
PMC: 11693621.
DOI: 10.1007/s12031-024-02241-3.
Ma B, Chan T, Lo B
Surg Neurol Int. 2024; 15:394.
PMID: 39640340
PMC: 11618647.
DOI: 10.25259/SNI_703_2024.
High Blood Pressure and Impaired Brain Health: Investigating the Neuroprotective Potential of Magnesium.
Alateeq K, Walsh E, Cherbuin N
Int J Mol Sci. 2024; 25(22).
PMID: 39595928
PMC: 11594239.
DOI: 10.3390/ijms252211859.
IL-17A-producing γδ T cells: A novel target in stroke immunotherapy.
Piepke M, Jander A, Gagliani N, Gelderblom M
Eur J Immunol. 2024; 54(12):e2451067.
PMID: 39396374
PMC: 11628885.
DOI: 10.1002/eji.202451067.
The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case-Control Study.
Frydrychowicz M, Telec M, Aniola J, Kazmierski R, Chowaniec H, Dworacki G
Cells. 2024; 13(16).
PMID: 39195289
PMC: 11352391.
DOI: 10.3390/cells13161401.
Changes in Neuroimmunological Synapses During Cerebral Ischemia.
Bitar L, Puig B, Oertner T, Denes A, Magnus T
Transl Stroke Res. 2024; .
PMID: 39103660
DOI: 10.1007/s12975-024-01286-1.
T cell interactions with microglia in immune-inflammatory processes of ischemic stroke.
Zheng Y, Ren Z, Liu Y, Yan J, Chen C, He Y
Neural Regen Res. 2024; 20(5):1277-1292.
PMID: 39075894
PMC: 11624874.
DOI: 10.4103/NRR.NRR-D-23-01385.
Exploring the therapeutic efficacy and pharmacological mechanism of Guizhi Fuling Pill on ischemic stroke: a meta-analysis and network pharmacology analysis.
Wang J, Li X, Long J, Gao Q, Pan M, Yang F
Metab Brain Dis. 2024; 39(6):1157-1174.
PMID: 39052207
DOI: 10.1007/s11011-024-01383-y.
Transcriptome Analysis of the Striatum of Electroacupuncture-treated Naïve and Ischemic Stroke Mice.
Lee H, Shin H, Kim J, Choi B
J Pharmacopuncture. 2024; 27(2):162-171.
PMID: 38948311
PMC: 11194526.
DOI: 10.3831/KPI.2024.27.2.162.
Effects of peripheral blood cells on ischemic stroke: Greater immune response or systemic inflammation?.
Gong H, Li Z, Huang G, Mo X
Heliyon. 2024; 10(11):e32171.
PMID: 38868036
PMC: 11168442.
DOI: 10.1016/j.heliyon.2024.e32171.
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation.
Li J, Wang Z, Li J, Zhao H, Ma Q
Transl Stroke Res. 2024; .
PMID: 38740617
DOI: 10.1007/s12975-024-01258-5.
Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke.
Duan M, Xu Y, Li Y, Feng H, Chen Y
J Neuroinflammation. 2024; 21(1):102.
PMID: 38637850
PMC: 11025216.
DOI: 10.1186/s12974-024-03101-y.
Immune cells: potential carriers or agents for drug delivery to the central nervous system.
Zhang S, Li R, Chen Z, Wang X, Dumont A, Fan X
Mil Med Res. 2024; 11(1):19.
PMID: 38549161
PMC: 10979586.
DOI: 10.1186/s40779-024-00521-y.
Effects of therapeutic hypercapnia on the expression and function of γδT cells in transplanted lungs in rats.
Xie Q, Lu J, Cui X
Immun Inflamm Dis. 2024; 12(3):e1220.
PMID: 38506409
PMC: 10953205.
DOI: 10.1002/iid3.1220.
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
Hediyal T, Vichitra C, Anand N, Bhaskaran M, Essa S, Kumar P
Front Immunol. 2024; 15:1324018.
PMID: 38449863
PMC: 10915229.
DOI: 10.3389/fimmu.2024.1324018.
Luminol-conjugated cyclodextrin biological nanoparticles for the treatment of severe burn-induced intestinal barrier disruption.
Song Y, Li Y, Hu W, Li F, Sheng H, Huang C
Burns Trauma. 2024; 12:tkad054.
PMID: 38444636
PMC: 10910847.
DOI: 10.1093/burnst/tkad054.
Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain.
Chevalier M, Al-Waeel M, Alsharabasy A, Rebelo A, Martin-Saldana S, Pandit A
Mol Pharm. 2024; 21(4):1609-1624.
PMID: 38412451
PMC: 10988560.
DOI: 10.1021/acs.molpharmaceut.3c00244.